We are live on ! Find out more
AVEO

AVEO Pharmaceuticals, Inc.
AVEO

Delisted

AVEO was delisted on the 19th of January, 2023.

Back to rankings

76 hedge funds and large institutions have $101M invested in AVEO Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

122% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 9

68% more capital invested

Capital invested by funds: $60.4M → $101M (+$40.9M)

38% more call options, than puts

Call options by funds: $7.28M | Put options by funds: $5.28M

17% more funds holding

Funds holding: 65 → 76 (+11)

11% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 19

Holders
76
Holders Change
+11
Holders Change %
+16.92%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
21
Reduced
19
Closed
9
Calls
$7.28M
Puts
$5.28M
Net Calls
+$2M
Net Calls Change
+$2.03M

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$12.9M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$8.32M
3
OM
Opaleye Management
Massachusetts
+$6.7M
4
CCP
Clough Capital Partners
Massachusetts
+$2.59M
5
MIM
Monashee Investment Management
Massachusetts
+$2.16M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$9.71M
2
JP Morgan Chase
JP Morgan Chase
New York
-$837K
3
Squarepoint
Squarepoint
New York
-$745K
4
Millennium Management
Millennium Management
New York
-$630K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$619K
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
26
Evercore Wealth Management
New York
$339K – – –
Goldman Sachs
27
Goldman Sachs
New York
$319K +$13.1K +1,523 +4%
AA
28
Ancora Advisors
Ohio
$295K +$34.5K +4,000 +11%
Jane Street
29
Jane Street
New York
$256K +$302K +35,017 New
Bank of America
30
Bank of America
North Carolina
$250K +$139K +16,111 +89%
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$242K – – –
VF
32
Virtu Financial
New York
$242K +$285K +33,081 New
Citadel Advisors
33
Citadel Advisors
Florida
$234K -$1.67K -193 -0.6%
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
$207K +$34.4K +3,984 +16%
SAM
35
Sectoral Asset Management
Quebec, Canada
$185K -$9.71M -1,125,875 -98%
AllianceBernstein
36
AllianceBernstein
Tennessee
$183K – – –
WMSA
37
Weiss Multi-Strategy Advisers
New York
$176K +$208K +24,056 New
Squarepoint
38
Squarepoint
New York
$174K -$745K -86,376 -78%
PCS
39
Personal CFO Solutions
New Jersey
$168K +$86.3K +10,000 +77%
ECM
40
ExodusPoint Capital Management
New York
$147K +$173K +20,072 New
M&T Bank
41
M&T Bank
New York
$146K – – –
RhumbLine Advisers
42
RhumbLine Advisers
Massachusetts
$146K +$630 +73 +0.4%
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$138K – – –
Susquehanna International Group
44
Susquehanna International Group
Pennsylvania
$137K -$619K -71,698 -79%
Simplex Trading
45
Simplex Trading
Illinois
$114K +$135K +15,654 New
XT
46
XTX Topco
Cayman Islands
$112K +$132K +15,292 New
Invesco
47
Invesco
Georgia
$102K -$21.8K -2,525 -15%
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$97K +$115K +13,275 New
Millennium Management
49
Millennium Management
New York
$85K -$630K -73,026 -86%
Verition Fund Management
50
Verition Fund Management
Connecticut
$84K +$99.1K +11,489 New
1
2
3 4

AVEO Hedge Fund Activity: Q1 2021 in Review

76 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in AVEO Pharmaceuticals, Inc. (AVEO) for Q1 2021, worth a combined $101M — up 68% from $60.4M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new AVEO positions and 9 closed out — a net gain of 11 holders — while 21 added to existing stakes and 19 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $12.9M. The largest seller was Sectoral Asset Management, cutting an estimated $9.71M.

  • 76 institutional investors held AVEO Pharmaceuticals, Inc. (AVEO) as of Q1 2021, up from 65 in Q4 2020.
  • Funds reported $101M of AVEO Pharmaceuticals, Inc. stock for Q1 2021, up 68% quarter-over-quarter.
  • 20 funds opened new AVEO Pharmaceuticals, Inc. positions in Q1 2021 and 9 closed out, a net change of +11 holders.
  • The largest AVEO Pharmaceuticals, Inc. buyer in Q1 2021 was Cormorant Asset Management, an estimated $12.9M added.
  • The largest AVEO Pharmaceuticals, Inc. seller in Q1 2021 was Sectoral Asset Management, an estimated $9.71M sold.

Based on aggregated 13F filings for Q1 2021.